1/54
Comprehensive vocabulary flashcards covering psychopharmacology, neurobiology, clinical actions, and side effects of stimulants (cocaine, amphetamines, cathinones), CNS depressants, antipsychotics, antidepressants, alcohol, nicotine, and xanthines.
Cocaine (Origin and Traditional Route)
A natural alkaloid derived from the leaves of the erythroxylon coca plant native to the Andes mountains in Bolivia and Peru, historically administered by chewing leaves held in the cheek to enhance energy.
Coca Paste
A crude, impure extract produced by soaking, mixing, and mashing coca leaves with an organic solvent like kerosene or gasoline, from which excess liquid is filtered out before further processing.
Cocaine Hydrochloride
The stable, water-soluble salt form of cocaine created from coca paste that can be snorted intranasally or dissolved in liquid for intravenous injection, but cannot be heated and smoked without decomposing.
Freebasing
A technique to produce smokable cocaine in which the hydrochloride salt is chemically removed using a volatile, highly flammable organic solvent (such as ether) to yield the pure cocaine base.
Crack Cocaine
A smokable form of cocaine produced by combining cocaine hydrochloride powder with baking soda and water and drying it, which avoids the use of explosive solvents.
Cocaine (Local Anesthetic Mechanism)
The interruption of action potential conduction along neural pathways accomplished by physically blocking the influx of Na+ ions through voltage-gated sodium channels into nerve cells.

Cocaine (Central Synaptic Mechanism)
The competitive inhibition of presynaptic reuptake transporters for monoamines—specifically dopamine, norepinephrine, and serotonin—which traps neurotransmitters in the synaptic cleft and potentiates their actions.
Cocaine Elimination Kinetics
Rapid hepatic and plasma enzymatic metabolism characterized by a half-life of approximately 1hour, with inactive metabolites taking approximately 3days for complete urinary excretion after moderate use.
Crack Baby Syndrome
A debunked medical hypothesis asserting that prenatal cocaine exposure causes permanent developmental defects and intellectual impairment; research showed maternal malnutrition, heavy alcohol use, and polydrug abuse were the actual confounding factors.
Amphetamine Historical Milestones
A timeline of development beginning with isolation of active components from Ephedra (ma huang), synthetic creation by Lazăr Edeleanu (1887), methamphetamine synthesis by Nagai Nagayoshi (1893) and Akira Ogata (1919), clinical marketing of Benzedrine/Dexedrine (1930s), widespread WWII military use, and federal scheduling in the 1970s.

Amphetamine Mechanism of Action
The promotion of monoamine neurotransmission (especially norepinephrine and dopamine) by entering presynaptic nerve terminals, displacing neurotransmitters from storage vesicles, and reversing transporter direction to stimulate direct release into the synaptic cleft.

Synthetic Cathinones
Amphetamine-like stimulant derivatives naturally derived from the East African shrub khat (Catha edulis), including compounds such as mephedrone and methcathinone, often marketed as 'bath salts.'
Chloral Hydrate
An early synthetic sedative-hypnotic synthesized in the 19th century, famously used by Chicago bartender 'Mickey Finn' to slip into patrons' drinks to knock them unconscious for robbery.
Paraldehyde
A potent CNS depressant introduced clinically in 1882 with effective sedative properties and minimal respiratory depression, but whose widespread clinical use was limited by an extremely noxious taste and offensive breath odor.
Barbiturates
The first widely prescribed family of synthetic sedative-hypnotic depressants, used as anticonvulsants, low-dose sedatives (30–50mg of phenobarbital), and high-dose hypnotics (100–200mg of secobarbital), carrying severe risks of fatal respiratory depression.
Methaqualone
A sedative-hypnotic non-barbiturate synthesized in India and introduced in Germany in 1960; despite initial claims of safety, rampant abuse, suicide cases, and addiction led to its Schedule II placement in 1973 and total Schedule I prohibition by 1985.
Chlordiazepoxide (Librium)
The first synthesized benzodiazepine, marketed in 1960 as an anxiolytic with a significantly wider margin of safety than barbiturates when ingested without other depressants.
Diazepam (Valium)
A potent, lower-dose, long-acting benzodiazepine introduced in the 1970s that became the single best-selling prescription drug in the United States between 1972 and 1978.
Flunitrazepam (Rohypnol)
A potent benzodiazepine marketed outside the United States as a hypnotic, which became notorious in the 1990s as a date-rape agent when dissolved unnoticed into alcoholic beverages.
Inhalants (Pharmacological Mechanism)
Volatile solvents (such as toluene and trichloroethane) that act as positive allosteric modulators at GABAA and glycine receptors, enhancing inhibitory post-synaptic potentials and suppressing general central nervous system excitability.
Nitrous Oxide
Known as 'laughing gas,' an inhalant first utilized clinically in the early 1800s that produces mild analgesia and euphoria but cannot induce safe surgical anesthesia alone without risking severe hypoxia.
Electroconvulsive Therapy (ECT)
A psychiatric intervention that applies electrical currents to the brain under general anesthesia and muscle relaxation to trigger controlled seizures, reserved for treatment-resistant depression and bipolar disorder.

DSM-5
The Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition), published by the American Psychiatric Association, which establishes standardized behavioral symptom criteria to classify mental illnesses in the absence of biological tests.
Neurodivergent
A framework recognizing that variations in human brain function, cognition, learning styles, and behavior represent natural diversity rather than singular pathology or a single 'right' neurological state.
Psychosis vs. Schizophrenia
Psychosis is an acute loss of reality contact (hallucinations/delusions) with diverse potential organic or drug etiologies, whereas schizophrenia is a chronic, lifelong psychiatric disorder diagnosed by exclusion lasting at least six months with positive, negative, and cognitive symptoms.

Antipsychotic Drug Mechanism
The selective antagonism of post-synaptic dopamine D2 receptors in mesolimbic and striatal pathways, alleviating aberrant salience of stimuli after a characteristic therapeutic latency of 10 to 14days.
Dopamine Receptor Supersensitivity / Rebound Psychosis
A compensatory upregulation in the number and sensitivity of dopamine receptors following long-term pharmacological antagonism, which causes excessive stimulation and severe withdrawal or rebound symptoms if medication is abruptly withdrawn.

Agranulocytosis
A severe, life-threatening suppression of white blood cell (neutrophil) bone marrow production, representing a critical adverse hematological side effect of the atypical antipsychotic clozapine.

Extrapyramidal Symptoms (EPS)
A spectrum of motor side effects produced by neuroleptic dopamine blockade in the nigrostriatal pathway, including pseudoparkinsonism (tremors, rigidity, shuffling gait), acute dystonia (spasms), and akathisia (motor restlessness).

Tardive Dyskinesia
An often irreversible movement disorder caused by long-term neuroleptic-induced dopamine receptor supersensitivity, presenting with involuntary choreiform movements such as tongue protrusion, lip smacking, rapid blinking, and pelvic thrusting.

Major Depressive Disorder (Diagnostic Criteria)
A mood condition diagnosed when an individual presents for at least two weeks with five or more core symptoms, which must include depressed mood or anhedonia (loss of interest/pleasure), alongside changes in weight, sleep, energy, and cognition.

Bipolar I Disorder
A psychiatric affective disorder diagnosed by the occurrence of at least one manic episode characterized by an abnormally elevated or irritable mood, grandiosity, reduced sleep need, pressured speech, and high-risk behaviors.
Monoamine Oxidase Inhibitors (MAOIs)
Antidepressants that inhibit the catabolic enzyme monoamine oxidase, elevating synaptic serotonin, dopamine, and norepinephrine levels, but requiring strict dietary restriction of tyramine to avoid fatal hypertensive crisis and stroke.
Tricyclic Antidepressants (TCAs)
A first-generation class of antidepressants discovered during research into phenothiazine antipsychotics that block the neuronal reuptake of norepinephrine, serotonin, and to a lesser extent dopamine.
Selective Serotonin Reuptake Inhibitors (SSRIs)
A modern class of antidepressants exemplified by fluoxetine (Prozac, introduced in 1987) that selectively inhibit presynaptic serotonin transporters, providing higher overdose safety and lower anticholinergic toxicity than TCAs.
Lithium Carbonate (Neurochemical Mechanism)
A mood-stabilizing monovalent cation used in bipolar disorder that increases cerebrospinal fluid GABA levels, enhances presynaptic GABA release, and upregulates postsynaptic GABAB receptors to normalize neural transmission.

Buspirone
A non-benzodiazepine anxiolytic that acts as a partial agonist at serotonin 5-HT1A receptors and modulates dopamine receptors, managing chronic anxiety without producing significant sedation, hypnosis, or physical dependence.
Alcohol Fermentation Equation
The biochemical reaction catalyzed by yeast enzymes converting simple hexose sugars into ethanol and carbon dioxide: C6H12O6→2C2H5OH+2CO2.
Distillation
The process of heating a fermented alcoholic solution to vaporize alcohol at a lower boiling point than water, condensing the vapors to produce distilled spirits exceeding 15% alcohol by volume.
Standard Drink Unit
A standardized alcoholic beverage containing approximately 0.5 to 0.6oz of pure ethanol, equivalent to 12oz of beer (4.5–5%), 5oz of table wine (12%), or 1.5oz of 80-proof distilled spirits (40%).

Alcohol Dehydrogenase (ADH)
A zinc-dependent oxidoreductase enzyme located in the gastric mucosa and liver that oxidizes ethanol into toxic acetaldehyde while reducing NAD+ to NADH+H+.
Aldehyde Dehydrogenase (ALDH) / Asian Flush Response
The hepatic mitochondrial enzyme converting acetaldehyde into acetate; a genetic deficiency in ALDH-2 leads to acetaldehyde buildup, elevated catecholamines, cutaneous vasodilation, tachycardia, and severe nausea.

Ethanol Clearance Rate
The zero-order hepatic metabolic clearance of ethanol occurring at an average constant rate of 0.25 to 0.30ounces of pure ethanol per hour in healthy adult humans.
Blood Alcohol Concentration (BAC) Stages
A graded continuum of physiological effects progressing from mild disinhibition (BAC=0.02–0.03%), motor/speech impairment (BAC=0.10%), dysphoria and nausea (BAC=0.16–0.20%), to stupor, respiratory arrest, and coma (BAC≥0.40%).

Alcohol Myopia
A cognitive impairment produced by ethanol intoxication where perception and attention are restricted strictly to immediate, salient situational cues while long-term consequences and risks are ignored.
Fetal Alcohol Syndrome (FAS)
A congenital disorder resulting from maternal alcohol intake during pregnancy, clinically identified by microcephaly, small palpebral fissures, a smooth philtrum, a thin upper lip, micrognathia, and irreversible central nervous system dysfunction.

Alcohol Withdrawal Syndrome Stages
A progressive physical withdrawal sequence consisting of autonomic hyperactivity and tremors (Stage 1), vivid hallucinations (Stage 2), global disorientation and delirium (Stage 3), and generalized tonic-clonic seizures (Stage 4).
Nicotine (Cholinergic Receptor Mechanism)
The biphasic stimulation followed by desensitizing depolarization block of nicotinic acetylcholine receptors (nAChRs), triggering the downstream exocytosis of dopamine, epinephrine, and norepinephrine.

Nicotine Acute Lethal Dose
The toxic quantity of pure nicotine sufficient to trigger fatal respiratory neuromuscular paralysis in humans, established at approximately 60mg (equivalent to the nicotine contained in two typical cigars).
Sidestream Smoke
The unfiltered, hazardous smoke that wafts directly into ambient air from the smoldering tip of a cigarette, containing significantly higher concentrations of carcinogens than inhaled mainstream smoke.
Caffeine (Adenosine Antagonism Mechanism)
The primary wakefulness-promoting action of 1,3,7-trimethylxanthine achieved by competitively blocking inhibitory A1 and A2A adenosine receptors across the brain, disinhibiting the release of excitatory neurotransmitters.

Theophylline
A dimethylxanthine present in tea leaves (Camellia sinensis) that exerts potent bronchodilatory and smooth muscle-relaxing effects, used clinically in the management of asthma.
Theobromine
A xanthine alkaloid found predominantly in cacao beans (Theobroma cacao) and chocolate, supplying approximately 200mg per cup of cocoa with substantially weaker CNS stimulant activity than caffeine.
Caffeine Withdrawal Headache
The hallmark physical dependence symptom following caffeine cessation caused by cerebral rebound vasodilation, emerging on average 18 to 19hours after the last dose.
Caffeine Acute Lethal Threshold
The quantity of caffeine estimated to produce fatal tonic-clonic convulsions and cardiovascular/respiratory arrest in humans, approximately 10grams (equivalent to consuming roughly 100cups of brewed coffee).